Published in: First Personal Medical Congress
COI code: IPMCMED01_146
Paper Language: English
How to Download This Paper
For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.
Authors Analysis of TRBP2 Gene Expression in Ovarian Cancer PatientsHosein Moharamzadeh - Tabriz university of medical sciences
Saeid Ghorbian - Department of Molecular Biology, Ahar Branch, Islamic Azad University, Ahar, Iran
Ali Dastranj Tabrizi - Pathology Laboratory, Alzahra Hospital, South Artesh Aven., Tabriz, Iran
Abstract:Introduction: Human trans-activation response (TAR) RNA binding protein 2 (TRBP2), a known molecular partner of the miRNA processing enzyme Dicer, which involved in RNA interference and microRNA pathways. Aberrant expression of TRBP2 is reported in several human cancers. Our aim was to assess the prognostic role of TRBP2 in ovarian cancer patients.Methods: TARBP2 mRNA expression levels were analyzed in 41 specimens, including 17high grade carcinoma and 13 normal ovarian tissue (from healthy woman) by quantitative real-time reverse transcriptase polymerase chain reaction.Results: The results of the study showed that there was no significant difference in the TARBP2 expression levels between normal ovarian tissue and tumoral tissue and also between different of tumoral grades (P > 0.05).Conclusions: In this study, the correlation between TRBP2 gene expression were not detected in ovarian cancer. Our findings suggest that TRBP2 is not an important prognostic marker in ovarian cancer and further investigation of other genes involved in this pathway is recommended.
Keywords:TRBP2, ovarian cancer, microRNA, Gene Expression, Grade
COI code: IPMCMED01_146
how to cite to this paper:If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Moharamzadeh, Hosein; Saeid Ghorbian & Ali Dastranj Tabrizi, 2016, Analysis of TRBP2 Gene Expression in Ovarian Cancer Patients, First Personal Medical Congress, تهران, دانشگاه علوم پزشكي ايران - پژوهشكده ملي مهندسي ژنتيك و زيست فناوري ايران، مركز همكاري هاي فناوري و نوآوري هاي رياست جمهوري, https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_146.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Moharamzadeh, Hosein; Saeid Ghorbian & Ali Dastranj Tabrizi, 2016)
Second and more: (Moharamzadeh; Ghorbian & Dastranj Tabrizi, 2016)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)
The University/Research Center Information:
Type: Medical University
Paper No.: 2416
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.
Research Info Management
Export Citation info of this paper to research management softwares
New Related Papers
- Prevalence of Musculoskeletal Disorders and Related Risk Factors among the Water-CounterManufacturer Workers
- Analysis of Cockroach Fauna and Frequency in Human Residential Habitats of North of Isfahan, Iran
- Prevalence of Cutaneous Leishmaniasis in Ramshir, Iran; an Epidemiological Study
- Analysis of Fang Puncture Wound Patterns in Isfahan Province’s, Iran, Venomous and Non-Venomous Snakes
- COD and Color Removal from Textile Wastewater Using Rosa damascena Watering Waste Ash
The Above articles are recently indexed in the related subjects
Iran Scientific Advertisment Netword
Share this paper
WHAT IS COI?
COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.